nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP1A2—Imiquimod—skin cancer	0.109	0.14	CbGbCtD
Almotriptan—CYP2C8—Vismodegib—skin cancer	0.098	0.125	CbGbCtD
Almotriptan—CYP2C19—Vismodegib—skin cancer	0.0822	0.105	CbGbCtD
Almotriptan—CYP2E1—Dacarbazine—skin cancer	0.0794	0.102	CbGbCtD
Almotriptan—CYP1A2—Vemurafenib—skin cancer	0.0599	0.0766	CbGbCtD
Almotriptan—CYP3A4—Imiquimod—skin cancer	0.0573	0.0732	CbGbCtD
Almotriptan—CYP3A4—Temozolomide—skin cancer	0.0573	0.0732	CbGbCtD
Almotriptan—CYP2D6—Vemurafenib—skin cancer	0.0494	0.0631	CbGbCtD
Almotriptan—CYP1A2—Dacarbazine—skin cancer	0.0459	0.0587	CbGbCtD
Almotriptan—CYP3A4—Vismodegib—skin cancer	0.0397	0.0508	CbGbCtD
Almotriptan—CYP2C8—Fluorouracil—skin cancer	0.0348	0.0445	CbGbCtD
Almotriptan—CYP3A4—Vemurafenib—skin cancer	0.0314	0.0401	CbGbCtD
Almotriptan—CYP1A2—Fluorouracil—skin cancer	0.0269	0.0344	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—skin cancer	0.0108	0.0138	CbGbCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000621	0.00286	CcSEcCtD
Almotriptan—Discomfort—Imiquimod—skin cancer	0.000618	0.00284	CcSEcCtD
Almotriptan—Sweating increased—Temozolomide—skin cancer	0.000615	0.00283	CcSEcCtD
Almotriptan—Dry mouth—Imiquimod—skin cancer	0.000612	0.00282	CcSEcCtD
Almotriptan—Bronchitis—Temozolomide—skin cancer	0.000608	0.0028	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000607	0.00279	CcSEcCtD
Almotriptan—Fatigue—Vemurafenib—skin cancer	0.000606	0.00279	CcSEcCtD
Almotriptan—Hypoaesthesia—Bleomycin—skin cancer	0.000596	0.00275	CcSEcCtD
Almotriptan—Muscular weakness—Fluorouracil—skin cancer	0.000594	0.00273	CcSEcCtD
Almotriptan—Shock—Imiquimod—skin cancer	0.00059	0.00271	CcSEcCtD
Almotriptan—Nervous system disorder—Imiquimod—skin cancer	0.000588	0.00271	CcSEcCtD
Almotriptan—Tachycardia—Imiquimod—skin cancer	0.000585	0.00269	CcSEcCtD
Almotriptan—Skin disorder—Imiquimod—skin cancer	0.000582	0.00268	CcSEcCtD
Almotriptan—Hyperhidrosis—Imiquimod—skin cancer	0.000579	0.00267	CcSEcCtD
Almotriptan—Photosensitivity reaction—Temozolomide—skin cancer	0.000577	0.00265	CcSEcCtD
Almotriptan—Hyperglycaemia—Temozolomide—skin cancer	0.00057	0.00262	CcSEcCtD
Almotriptan—Angina pectoris—Fluorouracil—skin cancer	0.000567	0.00261	CcSEcCtD
Almotriptan—Body temperature increased—Vemurafenib—skin cancer	0.000556	0.00256	CcSEcCtD
Almotriptan—Pharyngitis—Dactinomycin—skin cancer	0.000555	0.00255	CcSEcCtD
Almotriptan—Neuropathy peripheral—Temozolomide—skin cancer	0.000552	0.00254	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000546	0.00251	CcSEcCtD
Almotriptan—Insomnia—Imiquimod—skin cancer	0.000542	0.0025	CcSEcCtD
Almotriptan—Paraesthesia—Imiquimod—skin cancer	0.000538	0.00248	CcSEcCtD
Almotriptan—Chills—Bleomycin—skin cancer	0.000538	0.00248	CcSEcCtD
Almotriptan—Dyspnoea—Imiquimod—skin cancer	0.000534	0.00246	CcSEcCtD
Almotriptan—Somnolence—Imiquimod—skin cancer	0.000533	0.00245	CcSEcCtD
Almotriptan—Photosensitivity reaction—Fluorouracil—skin cancer	0.000531	0.00245	CcSEcCtD
Almotriptan—Sinusitis—Temozolomide—skin cancer	0.000528	0.00243	CcSEcCtD
Almotriptan—Dyspepsia—Imiquimod—skin cancer	0.000528	0.00243	CcSEcCtD
Almotriptan—Erythema—Bleomycin—skin cancer	0.000522	0.0024	CcSEcCtD
Almotriptan—Hypersensitivity—Vemurafenib—skin cancer	0.000518	0.00238	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Imiquimod—skin cancer	0.000518	0.00238	CcSEcCtD
Almotriptan—Fatigue—Imiquimod—skin cancer	0.000517	0.00238	CcSEcCtD
Almotriptan—Pain—Imiquimod—skin cancer	0.000513	0.00236	CcSEcCtD
Almotriptan—Acute coronary syndrome—Fluorouracil—skin cancer	0.000512	0.00236	CcSEcCtD
Almotriptan—Myocardial infarction—Fluorouracil—skin cancer	0.000509	0.00234	CcSEcCtD
Almotriptan—Neuropathy peripheral—Fluorouracil—skin cancer	0.000509	0.00234	CcSEcCtD
Almotriptan—Conjunctivitis—Fluorouracil—skin cancer	0.000504	0.00232	CcSEcCtD
Almotriptan—Asthenia—Vemurafenib—skin cancer	0.000504	0.00232	CcSEcCtD
Almotriptan—Hypoaesthesia—Temozolomide—skin cancer	0.000503	0.00232	CcSEcCtD
Almotriptan—Pharyngitis—Temozolomide—skin cancer	0.000502	0.00231	CcSEcCtD
Almotriptan—Chills—Dactinomycin—skin cancer	0.000502	0.00231	CcSEcCtD
Almotriptan—Pruritus—Vemurafenib—skin cancer	0.000497	0.00229	CcSEcCtD
Almotriptan—Feeling abnormal—Imiquimod—skin cancer	0.000494	0.00227	CcSEcCtD
Almotriptan—Gastrointestinal pain—Imiquimod—skin cancer	0.00049	0.00226	CcSEcCtD
Almotriptan—Epistaxis—Fluorouracil—skin cancer	0.000489	0.00225	CcSEcCtD
Almotriptan—Visual impairment—Temozolomide—skin cancer	0.000487	0.00224	CcSEcCtD
Almotriptan—Sinusitis—Fluorouracil—skin cancer	0.000487	0.00224	CcSEcCtD
Almotriptan—Erythema—Dactinomycin—skin cancer	0.000487	0.00224	CcSEcCtD
Almotriptan—Pain in extremity—Docetaxel—skin cancer	0.000486	0.00224	CcSEcCtD
Almotriptan—Ill-defined disorder—Bleomycin—skin cancer	0.000484	0.00223	CcSEcCtD
Almotriptan—Diarrhoea—Vemurafenib—skin cancer	0.000481	0.00221	CcSEcCtD
Almotriptan—Abdominal pain—Imiquimod—skin cancer	0.000474	0.00218	CcSEcCtD
Almotriptan—Body temperature increased—Imiquimod—skin cancer	0.000474	0.00218	CcSEcCtD
Almotriptan—Eye disorder—Temozolomide—skin cancer	0.000473	0.00218	CcSEcCtD
Almotriptan—Tinnitus—Temozolomide—skin cancer	0.000471	0.00217	CcSEcCtD
Almotriptan—Malaise—Bleomycin—skin cancer	0.000471	0.00217	CcSEcCtD
Almotriptan—Cardiac disorder—Temozolomide—skin cancer	0.000469	0.00216	CcSEcCtD
Almotriptan—Rhinitis—Fluorouracil—skin cancer	0.000467	0.00215	CcSEcCtD
Almotriptan—Dizziness—Vemurafenib—skin cancer	0.000465	0.00214	CcSEcCtD
Almotriptan—Hypoaesthesia—Fluorouracil—skin cancer	0.000464	0.00213	CcSEcCtD
Almotriptan—Pharyngitis—Fluorouracil—skin cancer	0.000462	0.00213	CcSEcCtD
Almotriptan—Immune system disorder—Temozolomide—skin cancer	0.000457	0.0021	CcSEcCtD
Almotriptan—Chills—Temozolomide—skin cancer	0.000454	0.00209	CcSEcCtD
Almotriptan—Ill-defined disorder—Dactinomycin—skin cancer	0.000452	0.00208	CcSEcCtD
Almotriptan—Vomiting—Vemurafenib—skin cancer	0.000447	0.00206	CcSEcCtD
Almotriptan—Chest pain—Bleomycin—skin cancer	0.000444	0.00205	CcSEcCtD
Almotriptan—Myalgia—Bleomycin—skin cancer	0.000444	0.00205	CcSEcCtD
Almotriptan—Abdominal pain upper—Docetaxel—skin cancer	0.000444	0.00204	CcSEcCtD
Almotriptan—Rash—Vemurafenib—skin cancer	0.000443	0.00204	CcSEcCtD
Almotriptan—Mental disorder—Temozolomide—skin cancer	0.000443	0.00204	CcSEcCtD
Almotriptan—Dermatitis—Vemurafenib—skin cancer	0.000443	0.00204	CcSEcCtD
Almotriptan—Hypersensitivity—Imiquimod—skin cancer	0.000442	0.00203	CcSEcCtD
Almotriptan—Headache—Vemurafenib—skin cancer	0.00044	0.00203	CcSEcCtD
Almotriptan—Erythema—Temozolomide—skin cancer	0.00044	0.00203	CcSEcCtD
Almotriptan—Breast disorder—Docetaxel—skin cancer	0.000439	0.00202	CcSEcCtD
Almotriptan—Discomfort—Bleomycin—skin cancer	0.000439	0.00202	CcSEcCtD
Almotriptan—Malaise—Dactinomycin—skin cancer	0.000439	0.00202	CcSEcCtD
Almotriptan—Dysgeusia—Temozolomide—skin cancer	0.000431	0.00198	CcSEcCtD
Almotriptan—Asthenia—Imiquimod—skin cancer	0.00043	0.00198	CcSEcCtD
Almotriptan—Confusional state—Bleomycin—skin cancer	0.000429	0.00198	CcSEcCtD
Almotriptan—Anaphylactic shock—Bleomycin—skin cancer	0.000426	0.00196	CcSEcCtD
Almotriptan—Back pain—Temozolomide—skin cancer	0.000426	0.00196	CcSEcCtD
Almotriptan—Pruritus—Imiquimod—skin cancer	0.000424	0.00195	CcSEcCtD
Almotriptan—Nausea—Vemurafenib—skin cancer	0.000418	0.00192	CcSEcCtD
Almotriptan—Vision blurred—Temozolomide—skin cancer	0.000415	0.00191	CcSEcCtD
Almotriptan—Myalgia—Dactinomycin—skin cancer	0.000414	0.00191	CcSEcCtD
Almotriptan—Tremor—Temozolomide—skin cancer	0.000412	0.0019	CcSEcCtD
Almotriptan—Diarrhoea—Imiquimod—skin cancer	0.00041	0.00189	CcSEcCtD
Almotriptan—Discomfort—Dactinomycin—skin cancer	0.000409	0.00188	CcSEcCtD
Almotriptan—Angina pectoris—Docetaxel—skin cancer	0.000409	0.00188	CcSEcCtD
Almotriptan—Ill-defined disorder—Temozolomide—skin cancer	0.000408	0.00188	CcSEcCtD
Almotriptan—Erythema—Fluorouracil—skin cancer	0.000406	0.00187	CcSEcCtD
Almotriptan—Agitation—Temozolomide—skin cancer	0.000404	0.00186	CcSEcCtD
Almotriptan—Angioedema—Temozolomide—skin cancer	0.000402	0.00185	CcSEcCtD
Almotriptan—Malaise—Temozolomide—skin cancer	0.000397	0.00183	CcSEcCtD
Almotriptan—Dizziness—Imiquimod—skin cancer	0.000396	0.00182	CcSEcCtD
Almotriptan—Vertigo—Temozolomide—skin cancer	0.000395	0.00182	CcSEcCtD
Almotriptan—Palpitations—Temozolomide—skin cancer	0.000389	0.00179	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000388	0.00179	CcSEcCtD
Almotriptan—Paraesthesia—Bleomycin—skin cancer	0.000382	0.00176	CcSEcCtD
Almotriptan—Vision blurred—Fluorouracil—skin cancer	0.000382	0.00176	CcSEcCtD
Almotriptan—Convulsion—Temozolomide—skin cancer	0.000381	0.00176	CcSEcCtD
Almotriptan—Vomiting—Imiquimod—skin cancer	0.000381	0.00175	CcSEcCtD
Almotriptan—Hypertension—Temozolomide—skin cancer	0.00038	0.00175	CcSEcCtD
Almotriptan—Dyspnoea—Bleomycin—skin cancer	0.00038	0.00175	CcSEcCtD
Almotriptan—Rash—Imiquimod—skin cancer	0.000378	0.00174	CcSEcCtD
Almotriptan—Dermatitis—Imiquimod—skin cancer	0.000378	0.00174	CcSEcCtD
Almotriptan—Headache—Imiquimod—skin cancer	0.000376	0.00173	CcSEcCtD
Almotriptan—Arthralgia—Temozolomide—skin cancer	0.000375	0.00173	CcSEcCtD
Almotriptan—Myalgia—Temozolomide—skin cancer	0.000375	0.00173	CcSEcCtD
Almotriptan—Anxiety—Temozolomide—skin cancer	0.000373	0.00172	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000372	0.00171	CcSEcCtD
Almotriptan—Discomfort—Temozolomide—skin cancer	0.00037	0.0017	CcSEcCtD
Almotriptan—Acute coronary syndrome—Docetaxel—skin cancer	0.000369	0.0017	CcSEcCtD
Almotriptan—Myocardial infarction—Docetaxel—skin cancer	0.000367	0.00169	CcSEcCtD
Almotriptan—Neuropathy peripheral—Docetaxel—skin cancer	0.000367	0.00169	CcSEcCtD
Almotriptan—Dry mouth—Temozolomide—skin cancer	0.000366	0.00169	CcSEcCtD
Almotriptan—Pain—Bleomycin—skin cancer	0.000364	0.00168	CcSEcCtD
Almotriptan—Conjunctivitis—Docetaxel—skin cancer	0.000364	0.00168	CcSEcCtD
Almotriptan—Confusional state—Temozolomide—skin cancer	0.000362	0.00167	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000362	0.00167	CcSEcCtD
Almotriptan—Anaphylactic shock—Temozolomide—skin cancer	0.000359	0.00165	CcSEcCtD
Almotriptan—Nausea—Imiquimod—skin cancer	0.000356	0.00164	CcSEcCtD
Almotriptan—Epistaxis—Docetaxel—skin cancer	0.000353	0.00163	CcSEcCtD
Almotriptan—Nervous system disorder—Temozolomide—skin cancer	0.000352	0.00162	CcSEcCtD
Almotriptan—Convulsion—Fluorouracil—skin cancer	0.000351	0.00162	CcSEcCtD
Almotriptan—Feeling abnormal—Bleomycin—skin cancer	0.000351	0.00162	CcSEcCtD
Almotriptan—Skin disorder—Temozolomide—skin cancer	0.000349	0.00161	CcSEcCtD
Almotriptan—Hyperhidrosis—Temozolomide—skin cancer	0.000347	0.0016	CcSEcCtD
Almotriptan—Chest pain—Fluorouracil—skin cancer	0.000345	0.00159	CcSEcCtD
Almotriptan—Myalgia—Fluorouracil—skin cancer	0.000345	0.00159	CcSEcCtD
Almotriptan—Fatigue—Dactinomycin—skin cancer	0.000342	0.00158	CcSEcCtD
Almotriptan—Discomfort—Fluorouracil—skin cancer	0.000341	0.00157	CcSEcCtD
Almotriptan—Pain—Dactinomycin—skin cancer	0.00034	0.00156	CcSEcCtD
Almotriptan—Rhinitis—Docetaxel—skin cancer	0.000337	0.00155	CcSEcCtD
Almotriptan—Body temperature increased—Bleomycin—skin cancer	0.000337	0.00155	CcSEcCtD
Almotriptan—Hypoaesthesia—Docetaxel—skin cancer	0.000335	0.00154	CcSEcCtD
Almotriptan—Confusional state—Fluorouracil—skin cancer	0.000334	0.00154	CcSEcCtD
Almotriptan—Pharyngitis—Docetaxel—skin cancer	0.000334	0.00154	CcSEcCtD
Almotriptan—Anaphylactic shock—Fluorouracil—skin cancer	0.000331	0.00152	CcSEcCtD
Almotriptan—Feeling abnormal—Dactinomycin—skin cancer	0.000327	0.00151	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000327	0.00151	CcSEcCtD
Almotriptan—Insomnia—Temozolomide—skin cancer	0.000325	0.0015	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000325	0.0015	CcSEcCtD
Almotriptan—Nervous system disorder—Fluorouracil—skin cancer	0.000325	0.00149	CcSEcCtD
Almotriptan—Visual impairment—Docetaxel—skin cancer	0.000324	0.00149	CcSEcCtD
Almotriptan—Tachycardia—Fluorouracil—skin cancer	0.000323	0.00149	CcSEcCtD
Almotriptan—Paraesthesia—Temozolomide—skin cancer	0.000323	0.00148	CcSEcCtD
Almotriptan—Dyspnoea—Temozolomide—skin cancer	0.00032	0.00147	CcSEcCtD
Almotriptan—Somnolence—Temozolomide—skin cancer	0.000319	0.00147	CcSEcCtD
Almotriptan—Dyspepsia—Temozolomide—skin cancer	0.000316	0.00146	CcSEcCtD
Almotriptan—Eye disorder—Docetaxel—skin cancer	0.000314	0.00145	CcSEcCtD
Almotriptan—Abdominal pain—Dactinomycin—skin cancer	0.000314	0.00145	CcSEcCtD
Almotriptan—Body temperature increased—Dactinomycin—skin cancer	0.000314	0.00145	CcSEcCtD
Almotriptan—Hypersensitivity—Bleomycin—skin cancer	0.000314	0.00144	CcSEcCtD
Almotriptan—Cardiac disorder—Docetaxel—skin cancer	0.000312	0.00144	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Temozolomide—skin cancer	0.00031	0.00143	CcSEcCtD
Almotriptan—Fatigue—Temozolomide—skin cancer	0.00031	0.00143	CcSEcCtD
Almotriptan—Pain—Temozolomide—skin cancer	0.000307	0.00141	CcSEcCtD
Almotriptan—Asthenia—Bleomycin—skin cancer	0.000306	0.00141	CcSEcCtD
Almotriptan—Immune system disorder—Docetaxel—skin cancer	0.000304	0.0014	CcSEcCtD
Almotriptan—Chills—Docetaxel—skin cancer	0.000302	0.00139	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000302	0.00139	CcSEcCtD
Almotriptan—Pruritus—Bleomycin—skin cancer	0.000301	0.00139	CcSEcCtD
Almotriptan—Insomnia—Fluorouracil—skin cancer	0.000299	0.00138	CcSEcCtD
Almotriptan—Paraesthesia—Fluorouracil—skin cancer	0.000297	0.00137	CcSEcCtD
Almotriptan—Feeling abnormal—Temozolomide—skin cancer	0.000296	0.00136	CcSEcCtD
Almotriptan—Dyspnoea—Fluorouracil—skin cancer	0.000295	0.00136	CcSEcCtD
Almotriptan—Mental disorder—Docetaxel—skin cancer	0.000295	0.00136	CcSEcCtD
Almotriptan—Somnolence—Fluorouracil—skin cancer	0.000294	0.00135	CcSEcCtD
Almotriptan—Gastrointestinal pain—Temozolomide—skin cancer	0.000294	0.00135	CcSEcCtD
Almotriptan—Erythema—Docetaxel—skin cancer	0.000293	0.00135	CcSEcCtD
Almotriptan—Hypersensitivity—Dactinomycin—skin cancer	0.000293	0.00135	CcSEcCtD
Almotriptan—Dyspepsia—Fluorouracil—skin cancer	0.000291	0.00134	CcSEcCtD
Almotriptan—Dysgeusia—Docetaxel—skin cancer	0.000287	0.00132	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000286	0.00132	CcSEcCtD
Almotriptan—Asthenia—Dactinomycin—skin cancer	0.000285	0.00131	CcSEcCtD
Almotriptan—Abdominal pain—Temozolomide—skin cancer	0.000284	0.00131	CcSEcCtD
Almotriptan—Body temperature increased—Temozolomide—skin cancer	0.000284	0.00131	CcSEcCtD
Almotriptan—Back pain—Docetaxel—skin cancer	0.000283	0.0013	CcSEcCtD
Almotriptan—Pain—Fluorouracil—skin cancer	0.000283	0.0013	CcSEcCtD
Almotriptan—Feeling abnormal—Fluorouracil—skin cancer	0.000273	0.00126	CcSEcCtD
Almotriptan—Diarrhoea—Dactinomycin—skin cancer	0.000272	0.00125	CcSEcCtD
Almotriptan—Vomiting—Bleomycin—skin cancer	0.000271	0.00125	CcSEcCtD
Almotriptan—Rash—Bleomycin—skin cancer	0.000269	0.00124	CcSEcCtD
Almotriptan—Dermatitis—Bleomycin—skin cancer	0.000268	0.00123	CcSEcCtD
Almotriptan—Hypersensitivity—Temozolomide—skin cancer	0.000265	0.00122	CcSEcCtD
Almotriptan—Syncope—Docetaxel—skin cancer	0.000262	0.00121	CcSEcCtD
Almotriptan—Body temperature increased—Fluorouracil—skin cancer	0.000262	0.0012	CcSEcCtD
Almotriptan—Palpitations—Docetaxel—skin cancer	0.000259	0.00119	CcSEcCtD
Almotriptan—Asthenia—Temozolomide—skin cancer	0.000258	0.00119	CcSEcCtD
Almotriptan—Loss of consciousness—Docetaxel—skin cancer	0.000257	0.00118	CcSEcCtD
Almotriptan—Pruritus—Temozolomide—skin cancer	0.000254	0.00117	CcSEcCtD
Almotriptan—Convulsion—Docetaxel—skin cancer	0.000254	0.00117	CcSEcCtD
Almotriptan—Nausea—Bleomycin—skin cancer	0.000253	0.00116	CcSEcCtD
Almotriptan—Hypertension—Docetaxel—skin cancer	0.000253	0.00116	CcSEcCtD
Almotriptan—Vomiting—Dactinomycin—skin cancer	0.000253	0.00116	CcSEcCtD
Almotriptan—Rash—Dactinomycin—skin cancer	0.00025	0.00115	CcSEcCtD
Almotriptan—Arthralgia—Docetaxel—skin cancer	0.000249	0.00115	CcSEcCtD
Almotriptan—Myalgia—Docetaxel—skin cancer	0.000249	0.00115	CcSEcCtD
Almotriptan—Chest pain—Docetaxel—skin cancer	0.000249	0.00115	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000247	0.00114	CcSEcCtD
Almotriptan—Diarrhoea—Temozolomide—skin cancer	0.000246	0.00113	CcSEcCtD
Almotriptan—Hypersensitivity—Fluorouracil—skin cancer	0.000244	0.00112	CcSEcCtD
Almotriptan—Dry mouth—Docetaxel—skin cancer	0.000244	0.00112	CcSEcCtD
Almotriptan—Confusional state—Docetaxel—skin cancer	0.000241	0.00111	CcSEcCtD
Almotriptan—Anaphylactic shock—Docetaxel—skin cancer	0.000239	0.0011	CcSEcCtD
Almotriptan—Dizziness—Temozolomide—skin cancer	0.000238	0.00109	CcSEcCtD
Almotriptan—Nausea—Dactinomycin—skin cancer	0.000236	0.00109	CcSEcCtD
Almotriptan—Shock—Docetaxel—skin cancer	0.000235	0.00108	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—skin cancer	0.000234	0.00108	CcSEcCtD
Almotriptan—Pruritus—Fluorouracil—skin cancer	0.000234	0.00108	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—skin cancer	0.000233	0.00107	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—skin cancer	0.000232	0.00107	CcSEcCtD
Almotriptan—Vomiting—Temozolomide—skin cancer	0.000228	0.00105	CcSEcCtD
Almotriptan—Rash—Temozolomide—skin cancer	0.000226	0.00104	CcSEcCtD
Almotriptan—Diarrhoea—Fluorouracil—skin cancer	0.000226	0.00104	CcSEcCtD
Almotriptan—Dermatitis—Temozolomide—skin cancer	0.000226	0.00104	CcSEcCtD
Almotriptan—Headache—Temozolomide—skin cancer	0.000225	0.00104	CcSEcCtD
Almotriptan—Dizziness—Fluorouracil—skin cancer	0.000219	0.00101	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000218	0.001	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—skin cancer	0.000216	0.000995	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—skin cancer	0.000215	0.000988	CcSEcCtD
Almotriptan—Nausea—Temozolomide—skin cancer	0.000213	0.000982	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—skin cancer	0.000213	0.00098	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—skin cancer	0.000212	0.000978	CcSEcCtD
Almotriptan—Vomiting—Fluorouracil—skin cancer	0.00021	0.000969	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—skin cancer	0.00021	0.000968	CcSEcCtD
Almotriptan—Rash—Fluorouracil—skin cancer	0.000209	0.000961	CcSEcCtD
Almotriptan—Dermatitis—Fluorouracil—skin cancer	0.000208	0.00096	CcSEcCtD
Almotriptan—Headache—Fluorouracil—skin cancer	0.000207	0.000955	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000206	0.000949	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—skin cancer	0.000206	0.000948	CcSEcCtD
Almotriptan—Pain—Docetaxel—skin cancer	0.000204	0.00094	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—skin cancer	0.000197	0.000906	CcSEcCtD
Almotriptan—Nausea—Fluorouracil—skin cancer	0.000197	0.000905	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—skin cancer	0.000195	0.000899	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—skin cancer	0.000189	0.000869	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—skin cancer	0.000189	0.000869	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—skin cancer	0.000176	0.00081	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—skin cancer	0.000171	0.000789	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—skin cancer	0.000169	0.000778	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—skin cancer	0.000163	0.000752	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—skin cancer	0.000158	0.000727	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—skin cancer	0.000152	0.000699	CcSEcCtD
Almotriptan—Rash—Docetaxel—skin cancer	0.000151	0.000693	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—skin cancer	0.00015	0.000693	CcSEcCtD
Almotriptan—Headache—Docetaxel—skin cancer	0.00015	0.000689	CcSEcCtD
Almotriptan—Nausea—Docetaxel—skin cancer	0.000142	0.000653	CcSEcCtD
Almotriptan—HTR1B—blood vessel—skin cancer	2.14e-05	0.0961	CbGeAlD
Almotriptan—HTR1D—blood vessel—skin cancer	2.07e-05	0.093	CbGeAlD
Almotriptan—MAOA—nerve—skin cancer	2.01e-05	0.0902	CbGeAlD
Almotriptan—FMO3—mammalian vulva—skin cancer	1.54e-05	0.0691	CbGeAlD
Almotriptan—MAOA—nipple—skin cancer	1.14e-05	0.0512	CbGeAlD
Almotriptan—MAOA—neck—skin cancer	1.13e-05	0.0507	CbGeAlD
Almotriptan—FMO3—head—skin cancer	1.1e-05	0.0495	CbGeAlD
Almotriptan—HTR1D—connective tissue—skin cancer	1.06e-05	0.0477	CbGeAlD
Almotriptan—CYP1A2—nipple—skin cancer	9.51e-06	0.0427	CbGeAlD
Almotriptan—MAOA—connective tissue—skin cancer	8.08e-06	0.0363	CbGeAlD
Almotriptan—HTR1B—female reproductive system—skin cancer	7.73e-06	0.0347	CbGeAlD
Almotriptan—FMO3—lymph node—skin cancer	7.71e-06	0.0346	CbGeAlD
Almotriptan—HTR1D—female reproductive system—skin cancer	7.48e-06	0.0336	CbGeAlD
Almotriptan—MAOA—mammalian vulva—skin cancer	6.66e-06	0.0299	CbGeAlD
Almotriptan—HTR1B—head—skin cancer	6.46e-06	0.029	CbGeAlD
Almotriptan—HTR1D—head—skin cancer	6.25e-06	0.0281	CbGeAlD
Almotriptan—MAOA—female reproductive system—skin cancer	5.7e-06	0.0256	CbGeAlD
Almotriptan—CYP2C8—female reproductive system—skin cancer	5.08e-06	0.0228	CbGeAlD
Almotriptan—MAOA—head—skin cancer	4.76e-06	0.0214	CbGeAlD
Almotriptan—CYP2E1—lymphoid tissue—skin cancer	4.44e-06	0.0199	CbGeAlD
Almotriptan—CYP2E1—female reproductive system—skin cancer	4.28e-06	0.0192	CbGeAlD
Almotriptan—CYP2E1—head—skin cancer	3.57e-06	0.0161	CbGeAlD
Almotriptan—CYP3A4—female reproductive system—skin cancer	3.44e-06	0.0155	CbGeAlD
Almotriptan—CYP2D6—female reproductive system—skin cancer	3.39e-06	0.0152	CbGeAlD
Almotriptan—MAOA—lymph node—skin cancer	3.33e-06	0.015	CbGeAlD
Almotriptan—CYP2D6—head—skin cancer	2.83e-06	0.0127	CbGeAlD
